Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
about
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaFracture risk and the use of a diuretic (indapamide SR) +/- perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease.Blood pressure and ageing.Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population useA multicenter, case-control study of the effects of antihypertensive therapy on orthostatic hypotension, postprandial hypotension, and falls in octo- and nonagenarians in residential care facilitiesGuidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspectiveThe management of the elderly with hypertension.Is the verdict out? A systematic review of pharmacotherapy for hypertension in the elderly.Ongoing trials involving angiotensin-converting enzyme inhibitors.Hypertension and the elderly: more than just blood pressure control.JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.Diuretics for cardiovascular prevention in the elderly.Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies.Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database.Secondary prevention of stroke in the elderly: focus on drug therapy.Managing hypertension: evidence supporting the 2013/2014 recommendations of the Canadian Hypertension Education Program.Kidney function and cognitive decline in an oldest-old Chinese populationACE inhibitors and the risk of fractures: a meta-analysis of observational studies.Clinical Implications of Different Blood Pressure Measurement Techniques.Operative fixation of unstable ankle fractures in patients aged over 80 years.Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET).Treatment of isolated systolic hypertension: the SHELL study results.The clock drawing test, mortality, incident cardiovascular events and dementia.Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols.Cognitive function and 3-year mortality in the very elderly Chinese population with chronic kidney diseaseHypertension in the elderly
P2860
Q24240206-F6FD6D1E-7886-4739-B903-70A86D51F2C3Q28212941-5F7EADDC-D7D3-4BFA-98E7-6ABAE2E52828Q30558607-41A7100B-2E97-4A52-9321-5A8DDCC405ABQ33159154-78D8ECD4-CB64-4E2B-850E-7850B31ED46EQ33588483-BE4DEA1E-E0D5-420E-B571-6DD7C9D4EB68Q33644458-BD56E3BC-B608-4E6A-9DF8-249CB14780C0Q33739027-881C07A4-51DD-40A1-A99A-AFAEF21C0B19Q34299778-E926BD9E-3B60-40D8-82E9-2AD94B0259EFQ34444643-CA407863-6422-4048-91A7-532E0AB90E00Q34553573-3D29D97D-717E-4CFB-918C-BE40254D23ACQ34731023-82C75031-1B9F-46FB-8FD0-A4C5A13532E4Q35001043-126A5DEF-66E4-477D-847D-7D657B1ECDDBQ35767490-7647DB74-DC6B-44EB-A987-E902BDE6214FQ35808362-72EEEEEC-70DF-4B2B-8EFB-D567D681C5A7Q35980982-AFD75CA5-F42C-47A2-80EC-FFC766CCE933Q36589348-14292B58-A45C-4269-B69E-CEE1F50F21F5Q37087367-C03719A1-88C9-400E-BEEF-43FFCE2583F0Q37320310-59CB5598-EC3E-4B55-B2F9-DD5A4FDD6BB8Q38248457-7E53D09E-8245-499F-A3FE-B6BCF7681A45Q38260387-ECE3C822-D8C2-47A2-AF50-50884287FF34Q38663451-68624CCB-6531-4832-AF4A-79733A89A29EQ39084846-CBD1DA16-9252-4369-AE2E-F676FF83233DQ39334583-0233D505-7FCC-4F20-B380-443B26E37DDEQ42607998-C8AE83F6-ACE2-4647-9040-B447D102FC3EQ44165287-74CA303F-3BBF-424C-AE94-8BC2E322FE48Q44521967-C9D223EA-F4E2-4F05-AE56-80F240B4CE84Q45212245-31ED3E46-6ADD-49CC-80DF-80C225EB24F9Q46105396-DBCDF27B-FD84-4D04-AFC9-AAE6A93590A8Q46120095-66FC7765-AA48-4EE3-A2AE-6B8C431028D9Q58698869-91B484FA-3CA7-4A42-889A-2582C35651DDQ58704504-2DB359C4-B414-462E-8965-46E7DA859281
P2860
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
@en
Hypertension in the Very Elderly Trial
@nl
type
label
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
@en
Hypertension in the Very Elderly Trial
@nl
prefLabel
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
@en
Hypertension in the Very Elderly Trial
@nl
P2093
P1433
P1476
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
@en
P2093
A Fletcher
B Gil-Extremera
P304
P356
10.2165/00002512-200118030-00001
P577
2001-01-01T00:00:00Z
P5875
P6179
1042174733